Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from in vitro allergen-release data - Archive ouverte HAL
Article Dans Une Revue Expert Review of Clinical Immunology Année : 2019

Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from in vitro allergen-release data

Giorgio Walter Canonica
Thomas Casale
Catherine Bos
Efstrathios Karagiannis
Giovanni Passalacqua
Ulrich Wahn
Laurent Mascarell

Dates et versions

hal-04265141 , version 1 (30-10-2023)

Identifiants

Citer

Giorgio Walter Canonica, Philippe Devillier, Thomas Casale, Pascal Demoly, Catherine Bos, et al.. Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from in vitro allergen-release data. Expert Review of Clinical Immunology, 2019, 15 (9), pp.921-928. ⟨10.1080/1744666X.2019.1649597⟩. ⟨hal-04265141⟩
11 Consultations
0 Téléchargements

Altmetric

Partager

More